Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Abbott Provides the Right Laboratory Solutions for Imperial College Healthcare

Published: Friday, November 30, 2012
Last Updated: Friday, November 30, 2012
Bookmark and Share
Abbott’s managed service contract provides trusts with a cost-effective, guaranteed service.

The Division of Infection and Immunity at Imperial College Healthcare NHS Trust is benefitting from a managed service contract with Abbott, ensuring an efficient and reliable service for one of Britain’s largest NHS trusts.

Consultant Virologist Mark Atkins explained: “The Trust has a catchment of almost 1.5 million people, and so it is vital that all our equipment functions as it should, or a backlog will quickly develop. We have been working with Abbott for many years, and we know we can rely on our ARCHITECT® platforms and other Abbott instruments to perform as expected. The full automation offered by these systems gives us the throughput and flexibility to deliver a high quality, efficient service for our clinicians; the lab simply wouldn’t work without them.”

“The benefits of our managed service contract were clearly demonstrated during the recent merger of microbiology, virology and immunology services into a single blood sciences group within the Trust. Our Abbott facilities manager was instrumental in this, co-ordinating the transfer of equipment so that it did not interrupt services or have an impact on patients. The Abbott team also helped us to develop more efficient combined workflows, listening to our needs and delivering solutions that matched our requirements. For example, we are now running syphilis assays on our ARCHITECT systems, meaning all antenatal samples can be run on a single analyzer, and we can also run a high performance HIV test on this platform.”

Rebecca Stalham, Marketing and Contracts Director at Abbott, added: “A managed service contract provides trusts with a cost-effective, guaranteed service, allowing laboratory staff to focus on high value work which ultimately leads to better patient care, and we are happy that this model is working so well for Imperial College Healthcare.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Abbott to Acquire Alere for $5B
Acquisition broadens Abbott's diagnostics footprint by providing access to new product applications, channels and geographies.
Monday, February 01, 2016
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
A Peachy Defense System for Seeds
ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!